Skip to content
Research Fellows Directory

Rupesh Chikhale

Dr Rupesh Chikhale

Research Fellow


University of Manchester

Research summary

My present research deals with the development of chemically diverse and biologically active molecules, which can be further developed in to new chemical entity. Major focus of work is based on receptor-ligand theory, the target receptors are mostly the proteins functioning as enzymes, several other types of targets include the functional channels, trans-membrane proteins and G-protein coupled receptors. The ligand or molecules are rationally designed and synthesised on the basis of high throughput virtual screening (HTVS), molecular docking and molecular dynamics protocols, these are further characterized for their structural elucidation and purity. Multistep synthesis and appropriate catalytic methods are involved and special emphasis is given on the use of green catalyst so as to reduce the cost of synthesis and possible pollution. These molecules are further evaluated by suitable in vitro, ex vivo and in vivo assays for their biological activity. Advances are made on the basis of results obtained; promising compounds are studied for their pharmacokinetic and pharmacodynamics studies. The Computer Aided Drug Discovery (CADD) process forms the backbone of these studies. CADD has developed into Structure Based Drug Design (SBDD), Quantitative Structure Activity Relationship (QSAR) and pharmacogenomics. SBDD has yielded with several new compounds with better anticancer, anticonvulsant (antiepileptic), antihypertensive and anti-mycobacterial (anti-TB) agents in our laboratory.

Interests and expertise (Subject groups)

Grants awarded

Targetting R-spondin structure and dynamics: chemical tools for Wnt-related biology and disease

Scheme: Newton International Fellowships

Dates: Mar 2017 - Mar 2019

Value: £99,000

Was this page useful?
Thank you for your feedback
Thank you for your feedback. Please help us improve this page by taking our short survey.